Researchers from Capital Medical University Report on Findings in Autism (Prenatal exposure to antiseizure medications and risk of autism spectrum disorder in offspring: an integrated pharmacovigilance and two-sample mendelian randomization...).

This article focuses on research from Capital Medical University in Beijing, People's Republic of China, examining the association between prenatal exposure to antiseizure medications (ASMs) and the risk of autism spectrum disorder (ASD) in offspring. Using pharmacovigilance data from the FDA Adverse Event Reporting System, the European Medicines Agency, and the UK Medicines and Healthcare Products Regulatory Agency, combined with Mendelian randomization analyses, the study identified valproate (VPA), carbamazepine (CBZ), and lamotrigine (LTG) as ASMs linked to increased ASD risk. The research highlights potential biological pathways involved and emphasizes cautious ASM selection during pregnancy to minimize risk. The authors recommend large, prospective multicenter studies to confirm these findings and clarify dose-response relationships. [Extracted from the article]